(redirected from AA amyloidosis)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to AA amyloidosis: AL amyloidosis, reactive amyloidosis


Any of a group of diseases or conditions characterized by the formation and deposition of amyloid in various organs and tissues of the body.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


(Pathology) pathol the deposition of amyloid in various tissues of the body, as occurs in certain chronic infections
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.amyloidosis - a disorder characterized by deposit of amyloid in organs or tissues; often secondary to chronic rheumatoid arthritis or tuberculosis or multiple myeloma
illness, sickness, unwellness, malady - impairment of normal physiological function affecting part or all of an organism
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.


n. amiloidosis, acumulación de amiloide en los tejidos.
English-Spanish Medical Dictionary © Farlex 2012


n amiloidosis f
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
EULAR also stated that patients with FMF and AA amyloidosis should receive an intensified treatment with a maximal tolerable colchicine dose and biological treatment as required (9).
Systemic AA amyloidosis: epidemiology, diagnosis, and management.
In addition, despite etanercept, her inflammatory markers remained significantly raised between attacks: CRP 82 mg/L (reference range [RR] < 10); serum amyloid A (SAA) 1310 mg/L (RR < 10), indicative of severe systemic inflammation in-between attacks and significant risk of reactive AA amyloidosis. Anakinra (2 mg/kg/day; recombinant interleukin-1 receptor antagonist) had also been tried previously, but was complicated both by a severe skin rash and also by the worst disease flare she had ever experienced; hence after four weeks, this was discontinued.
Gilbertson et al., "Natural history and outcome in systemic AA amyloidosis," The New England Journal of Medicine, vol.
The treatment goal of AA amyloidosis is to control the underlying inflammatory disease.
The most common forms of amyloidosis include systemic AL amyloidosis (formerly primary amyloidosis), systemic AA amyloidosis (formerly secondary amyloidosis), systemic wild-type ATTR amyloidosis (formerly age-related or senile systemic amyloidosis), systemic hereditary ATTR amyloidosis (formerly familial amyloid polyneuropathy), and localized AL amyloidosis (Table 1).
The prevalence of AA amyloidosis in the general population is below 1% while in RA it ranges from 5 to 20% [52].
Clinical findings of amyloid cardiomyopathy are found in 50 percent of patients with AL amyloidosis, while only under 5% of AA amyloidosis patients develop this [8,9].
Unicentric Castleman's disease complicated by systemic AA amyloidosis: A curable disease.
Sipe, "Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis," Amyloid, vol.
AA amyloidosis is the most frequent, found in 42 to 66% of amyloidoses.
(1) A significant association between chronic inflammatory states and fatal AA amyloidosis has also been described in falcons (Falco species) of the Middle East.